SpyGlass单人操作胆道镜系统对胆道疾病的诊治价值

赵思; 巫雪茹; 殷霖霖; 缪林; 季国忠; 张秀华

doi:10.3969/j.issn.1001-5256.2021.10.027

SpyGlass单人操作胆道镜系统对胆道疾病的诊治价值

DOI: 10.3969/j.issn.1001-5256.2021.10.027

南京医科大学第二附属医院消化医学中心，南京 210011

基金项目:

南京医科大学校基金重点项目 (2017NJMUZD03)

利益冲突声明：本研究不存在研究者、伦理委员会成员、受试者监护人以及与公开研究成果有关的利益冲突。

作者贡献声明：赵思负责课题设计及撰写论文；巫雪茹、殷霖霖负责文章的整体框架设计及修改，并最终定稿；缪林、季国忠、张秀华拟定写作思路，指导文章撰写。

详细信息

通信作者:
张秀华，1129wy@sina.com

中图分类号: R575.6
计量
- 文章访问数: 916
- HTML全文浏览量: 191
- PDF下载量: 42
- 被引次数: 0
出版历程
- 收稿日期: 2021-02-27
- 录用日期: 2021-05-07
- 出版日期: 2021-10-20

Value of SpyGlass single-operator choledochoscopy system in the diagnosis and treatment of patients with biliary tract diseases

Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University, Nanjing 210011, China

Research funding:

Key Projects of Nanjing Medical University (2017NJMUZD03)

摘要

摘要: 目的评估SpyGlass单人操作胆道镜系统对不明原因的胆管狭窄、复杂胆管结石及其他胆道疾病的诊疗价值。方法回顾性收集2017年12月—2020年6月在南京医科大学第二附属医院行SpyGlass下诊治胆道疾病患者的临床资料。胆管狭窄患者在SpyGlass引导下对病灶部位进行充分可视化，必要时取活检；胆管结石患者行SpyGlas胆道镜直视下激光碎石；胆囊病变患者通过SpyGlass辅助下超选胆囊管。分析SpyGlass系统诊治的敏感度、特异度、准确度、碎石成功率、结石清除率、操作成功率以及并发症发生率。结果共有58例患者进行SpyGlass操作。44例(76%)用于评估性质不明的胆道狭窄，SpyGlass视觉印象的诊断敏感度为92%(24/26)，特异度为94%(17/18)，准确度为93%(41/44)，SpyBite直视活检的诊断敏感度为71%(15/21)，特异度为92%(11/12)，准确度为79%(26/33)；8例(14%)用于胆管结石的治疗，碎石成功率为83%(5/6)，结石清除率为88%(7/8)；5例(9%)用于SpyGlass下引导导丝超选胆囊管，操作成功率为80%(4/5)；1例(1%)用于肝移植术后合并胆总管结石的辅助取石及胆管吻合口狭窄的治疗。术后共有5例(9%)患者出现并发症。结论 SpyGlass胆道镜系统能准确、安全、有效地应用于不明原因的胆管狭窄、复杂胆管结石以及其他胆道疾病的诊治。
- SpyGlass /
- 胆道疾病 /
- 诊断 /
- 治疗学
Abstract: Objective To investigate the value of SpyGlass single-operator choledochoscopy system in the diagnosis and treatment of patients with unexplained biliary stricture, complex bile duct stones, or other biliary tract diseases. Methods A retrospective analysis was performed for the clinical data of the patients with biliary tract diseases who were diagnosed and treated with SpyGlass in The Second Affiliated Hospital of Nanjing Medical University from December 2017 to June 2020. For the patients with biliary stricture, the biliary lesions were fully visualized under the guidance of SpyGlass, and SpyBite biopsy was performed if necessary; the patients with bile duct stones were treated with SpyGlass-guided direct-view laser lithotripsy; for the patients with gallbladder disease, the cystic duct was superselected with the assistance of SpyGlass. The SpyGlass system was analyzed in terms of its sensitivity, specificity, and accuracy rate in diagnosis and treatment, lithotripsy success rate, stone clearance rate, procedure success rate, and incidence rate of complications. Results A total of 58 patients underwent SpyGlass procedure. SpyGlass was used to evaluate biliary stricture of unknown nature in 44 (76%) patients; SpyGlass visual impression had a diagnostic sensitivity of 92% (24/26), a specificity of 94% (17/18), and an accuracy of 93% (41/44), and SpyBite biopsy had a diagnostic sensitivity of 71% (15/21), a specificity of 92% (11/12), and an accuracy of 79% (26/33). SpyGlass was used for the treatment of bile duct stones in 8 patients (14%), with a lithotripsy success rate of 83% (5/6) and a stone clearance rate of 88% (7/8). A guide wire under the SpyGlass system was to superselect the cystic duct in 5 patients (9%), with a procedure success rate of 80% (4/5). In one patient (1%), SpyGlass was used to assist the removal of common bile duct stones after liver transplantation and the treatment of bile duct anastomotic stricture. A total of 5 patients (9%) experienced complications after surgery. Conclusion The SpyGlass choledochoscopy system is accurate, safe, and effective in the diagnosis and treatment of unexplained biliary stricture, complex bile duct stones, and other biliary tract diseases.
- SpyGlass /
- Biliary Tract Diseases /
- Diagnosis /
- Therapeutics

HTML全文

图 1 胆管良恶性狭窄内镜下表现

注：a，ERCP示胆总管中下段充盈缺损；b，SpyGlass见胆管同心圆样增生，表面光滑(良性狭窄)；c，ERCP示胆总管中上段充盈缺损；d，SpyGlass见胆管绒毛状增生伴扭曲的血管(恶性狭窄)。

下载: 全尺寸图片幻灯片

参考文献(23)

[1]	CHEN YK. Preclinical characterization of the Spyglass peroral cholangiopancreatoscopy system for direct access, visualization, and biopsy[J]. Gastrointest Endosc, 2007, 65(2): 303-311. DOI: 10.1016/j.gie.2006.07.048.
[2]	DERDEYN J, LALEMAN W. Current role of endoscopic cholangioscopy[J]. Curr Opin Gastroenterol, 2018, 34(5): 301-308. DOI: 10.1097/MOG.0000000000000457.
[3]	XU W, MIAO L, WANG ZF, et al. Application of SpyGlassTM DS Direct Visualization System in the diagnosis and treatment of biliary tract diseases[J]. J Clin Hepatol, 2020, 36(11): 2626-2629. DOI: 10.3969/j.issn.1001-5256.2020.11.052. 徐雯, 苗龙, 王正峰, 等. SpyGlassTM DS直视化系统在胆道疾病诊疗中的应用[J]. 临床肝胆病杂志, 2020, 36(11): 2626-2629. DOI: 10.3969/j.issn.1001-5256.2020.11.052.
[4]	KARAGYOZOV P, BOEVA I, TISHKOV I. Role of digital single-operator cholangioscopy in the diagnosis and treatment of biliary disorders[J]. World J Gastrointest Endosc, 2019, 11(1): 31-40. DOI: 10.4253/wjge.v11.i1.31.
[5]	YODICE M, CHOMA J, TADROS M. The expansion of cholangioscopy: Established and investigational uses of SpyGlass in biliary and pancreatic disorders[J]. Diagnostics (Basel), 2020, 10(3): 132. DOI: 10.3390/diagnostics10030132.
[6]	NAVANEETHAN U, NJEI B, LOURDUSAMY V, et al. Comparative effectiveness of biliary brush cytology and intraductal biopsy for detection of malignant biliary strictures: A systematic review and meta-analysis[J]. Gastrointest Endosc, 2015, 81(1): 168-176. DOI: 10.1016/j.gie.2014.09.017.
[7]	SHAH RJ, RAIJMAN I, BRAUER B, et al. Performance of a fully disposable, digital, single-operator cholangiopancreatoscope[J]. Endoscopy, 2017, 49(7): 651-658. DOI: 10.1055/s-0043-106295.
[8]	TUROWSKI F, HVGLE U, DORMANN A, et al. Diagnostic and therapeutic single-operator cholangiopancreatoscopy with SpyGlassDS^TM: Results of a multicenter retrospective cohort study[J]. Surg Endosc, 2018, 32(9): 3981-3988. DOI: 10.1007/s00464-018-6141-0.
[9]	LENZE F, BOKEMEYER A, GROSS D, et al. Safety, diagnostic accuracy and therapeutic efficacy of digital single-operator cholangioscopy[J]. United European Gastroenterol J, 2018, 6(6): 902-909. DOI: 10.1177/2050640618764943.
[10]	SUN X, ZHOU Z, TIAN J, et al. Is single-operator peroral cholangioscopy a useful tool for the diagnosis of indeterminate biliary lesion? A systematic review and meta-analysis[J]. Gastrointest Endosc, 2015, 82(1): 79-87. DOI: 10.1016/j.gie.2014.12.021.
[11]	NAVANEETHAN U, HASAN MK, LOURDUSAMY V, et al. Single-operator cholangioscopy and targeted biopsies in the diagnosis of indeterminate biliary strictures: A systematic review[J]. Gastrointest Endosc, 2015, 82(4): 608-614. e2. DOI: 10.1016/j.gie.2015.04.030.
[12]	de OLIVEIRA P, DE MOURA D, RIBEIRO IB, et al. Efficacy of digital single-operator cholangioscopy in the visual interpretation of indeterminate biliary strictures: A systematic review and meta-analysis[J]. Surg Endosc, 2020, 34(8): 3321-3329. DOI: 10.1007/s00464-020-07583-8.
[13]	YASUDA I, ITOI T. Recent advances in endoscopic management of difficult bile duct stones[J]. Dig Endosc, 2013, 25(4): 376-385. DOI: 10.1111/den.12118.
[14]	RAMCHANDANI M, REDDY DN, LAKHTAKIA S, et al. Per oral cholangiopancreatoscopy in pancreatico biliary diseases-expert consensus statements[J]. World J Gastroenterol, 2015, 21(15): 4722-4734. DOI: 10.3748/wjg.v21.i15.4722.
[15]	BREWER GUTIERREZ OI, BEKKALI N, RAIJMAN I, et al. Efficacy and safety of digital single-operator cholangioscopy for difficult biliary stones[J]. Clin Gastroenterol Hepatol, 2018, 16(6): 918-926. e1. DOI: 10.1016/j.cgh.2017.10.017.
[16]	ALJEBREEN AM, ALHARBI OR, AZZAM N, et al. Efficacy of spyglass-guided electrohydraulic lithotripsy in difficult bile duct stones[J]. Saudi J Gastroenterol, 2014, 20(6): 366-370. DOI: 10.4103/1319-3767.145329.
[17]	ABURAJAB M, DUA K. Endoscopic management of difficult bile duct stones[J]. Curr Gastroenterol Rep, 2018, 20(2): 8. DOI: 10.1007/s11894-018-0613-1.
[18]	BOKEMEYER A, GERGES C, LANG D, et al. Digital single-operator video cholangioscopy in treating refractory biliary stones: A multicenter observational study[J]. Surg Endosc, 2020, 34(5): 1914-1922. DOI: 10.1007/s00464-019-06962-0.
[19]	SETHI A, CHEN YK, AUSTIN GL, et al. ERCP with cholangiopancreatoscopy may be associated with higher rates of complications than ERCP alone: A single-center experience[J]. Gastrointest Endosc, 2011, 73(2): 251-256. DOI: 10.1016/j.gie.2010.08.058.
[20]	NGUYEN NQ. Getting most out of SpyGlass cholangio-pancreatoscopy: How and when?[J]. J Gastroenterol Hepatol, 2012, 27(8): 1263-1265. DOI: 10.1111/j.1440-1746.2012.07178.x.
[21]	LALEMAN W, VERRAES K, VAN STEENBERGEN W, et al. Usefulness of the single-operator cholangioscopy system SpyGlass in biliary disease: A single-center prospective cohort study and aggregated review[J]. Surg Endosc, 2017, 31(5): 2223-2232. DOI: 10.1007/s00464-016-5221-2.
[22]	NJEI B, MCCARTY TR, VARADARAJULU S, et al. Cost utility of ERCP-based modalities for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis[J]. Gastrointest Endosc, 2017, 85(4): 773-781. e10. DOI: 10.1016/j.gie.2016.08.020.
[23]	ANG TL, KWEK A. Safety and efficacy of SpyGlass cholangiopancreatoscopy in routine clinical practice in a regional Singapore hospital[J]. Singapore Med J, 2019, 60(10): 538-544. DOI: 10.11622/smedj.2018158.